A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
From MaRDI portal
Publication:3201542
DOI10.2307/2531495zbMATH Open0715.62239OpenAlexW2088971961WikidataQ44153743 ScholiaQ44153743MaRDI QIDQ3201542FDOQ3201542
Authors: Peter F. Thall, Susan S. Ellenberg, Richard Simon 
Publication date: 1989
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531495
Recommendations
- Two-stage selection and testing designs for comparative clinical trials
- Adaptive two-stage test procedures to find the best treatment in clinical trials
- One-Stage and Two-Stage Designs for Clinical Trials Using an Indifference-Zone Approach
- A two-stage design for comparative clinical trials: the heteroscedastic solution
- scientific article; zbMATH DE number 1361707
Cited In (31)
- On estimating the mean of the selected normal population in two-stage adaptive designs
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment in Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment” by Elena M. Buzaianu and Pinyuen Chen
- Optimal Two-Stage Design for a Series of Pilot Trials of New Agents
- A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance
- A selection and testing procedure for comparing several experimental treatments with a control
- One-Stage and Two-Stage Designs for Clinical Trials Using an Indifference-Zone Approach
- Estimation following selection of the largest of two normal means
- Parameter estimation following an adaptive treatment selection trial design
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard
- A two-stage design for comparative clinical trials: the heteroscedastic solution
- Some results on two-stage clinical trials
- Two‐Stage Designs for Dose‐Finding Trials with a Biologic Endpoint Using Stepwise Tests
- Design and sample size determination for multiple-dose randomized phase II trials for dose optimization
- Point estimates and confidence regions for sequential trials involving selection
- Point estimation for adaptive trial designs. II: Practical considerations and guidance
- Two-stage selection and testing designs for comparative clinical trials
- Adaptive two-stage test procedures to find the best treatment in clinical trials
- Admissible and minimax estimation of the parameters of the selected normal population in two-stage adaptive under reflected normal loss function
- Statistical tests for two-stage adaptive seamless design using short- and long-term binary outcomes
- Choosing sample size for a clinical trial using decision analysis
- Bayesian approach to two-stage phase trial
- Multistage decission problems
- Two-Stage Experimental Designs: Early Stopping with a Negative Result
- Optimizing Sample Size Allocation and Power in a Bayesian Two-Stage Drop-the-Losers Design
- Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin
- Title not available (Why is that?)
- A multi-armed Bayesian ordinal outcome utility-based sequential trial with a pairwise null clustering prior
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- A review of phase 2-3 clinical trial designs
This page was built for publication: A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201542)
